Frontlight ResearchEarly access
Trial site
University of Tennessee
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease1 trial
- Chronic kidney disease1 trial
- Sickle cell disease1 trial
- Type 2 diabetes1 trial
- Vascular dementia1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Boehringer Ingelheim1 trial
- Marinella Temprosa1 trial
- National Institute on Drug Abuse (NIDA)1 trial
- Novo Nordisk A/S1 trial
Running trials
Active, not recruiting
Active, not recruiting
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Enrolling by invitation
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Type 2 diabetes1 recruiting
- Vascular dementia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026